Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

NCT00002721 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: doxorubicin hydrochloride
DRUG: estramustine phosphate sodium
PROCEDURE: drug resistance inhibition treatment

Sponsor

University of New Mexico